EBC - ON DEMAND
European Bifurcation Club 2011 – EBC 2011 – Lisbon, Portugal
Biosensors sponsored symposium
AXXESS – The Self-Expanding Bifurcation DES– Device Overview and Clinical Data
Author: Ricardo A. Costa, Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil
DEVICE DESCRIPTION
- Self-expanding nickel- titanium (Nitinol) alloy
- Conical shape
- Coated with Biolimus A9TM using a bioabsor-bable polymer matrix (PLA) in a dose of 22 μg/mm of stent length
- Proximal and distal gold markers to facilitate implantation
- First self-expanding coronary stent to incorporate a drug
- First drug-eluting stent dedicated for the treatment of diseased coronary bifurcation lesions
CONCLUSION
- The safety and efficacy of the Axxess Biolimus A9-eluting stent was confirmed up to 3 years
- The use of Axxess stent for the treatment of complex bifurcation lesions resulted in low 3-year event rates:
- Very low definite VLST not resulting in any death
- Only one definite VLST attributed to the Axxess stent whereas all events were present in the Cypher stent
??